| | | | | |
AARD Aardvark Therapeutics, Inc. Common Stock | €5,1072 | -2,95% | €109,31M | €73,33K | |
FXAC FortuneX Acquisition Corporation Ordinary shares | €8,6788 | +0,00% | €109,19M | €534,87 | |
INVZ Innoviz Technologies Ltd. Ordinary shares | €0,28737 | -3,59% | €109,15M | €1,80M | |
SJT San Juan Basin Royalty Trust UBI | €2,4587 | +3,26% | €108,96M | €60,54K | |
SANG Sangoma Technologies Corporation Common Shares | €3,3386 | -2,12% | €108,80M | €9,70K | |
CBUS Cibus, Inc. Class A Common Stock | €1,3415 | -4,01% | €108,79M | €120,33K | |
RDZN Roadzen, Inc. Ordinary Shares | €1,1992 | -1,42% | €108,73M | €290,53K | |
NYXH Nyxoah SA Ordinary Shares | €1,2897 | -4,17% | €108,73M | €68,76K | |
MXCT MaxCyte, Inc. Common Stock | €1,0784 | -3,10% | €108,62M | €585,68K | |
| €16,7752 | +0,44% | €108,51M | €817,83 | |
GGZ The Gabelli Global Small and Mid Cap Value Trust | €13,9671 | -1,40% | €108,39M | €3,38K | |
NMI Nuveen Municipal Income | €9,0152 | +0,00% | €108,36M | €33,05K | |
| €1,0611 | +5,13% | €108,32M | €303,01K | |
BMEA Biomea Fusion, Inc. Common Stock | €1,5529 | +7,14% | €108,18M | €1,95M | |
LIXT Lixte Biotechnology Holdings, Inc. Common Stock | €6,2848 | +1,04% | €108,14M | €526,84K | |
